1.
Mehani R, Shukla A, Yadav VK, Sahu R. Evolocumab: rising momentum as novel antidyslipidemic drug. Int J Basic Clin Pharmacol [Internet]. 2017 Jun. 23 [cited 2025 Oct. 24];6(7):1538-44. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/1671